Evidence map›Paper›PMID 35373295›Full record

ArticleJournal of public health (Oxford, England)2023

Tackling barriers to COVID-19 vaccine uptake in London: a mixed-methods evaluation.

Kristoffer Halvorsrud, Jenny Shand, Leonora G Weil, Andrew Hutchings, Ana Zuriaga, Dane Satterthwaite, Jennifer L Y Yip, Cyril Eshareturi, Julie Billett, Ann Hepworth and 12 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of public health (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Kristoffer HalvorsrudDepartment of Applied Health Research, University College London (UCL), London WC1E 7HB, UK.ORCID 0000-0002-8813-0939
Jenny ShandUCLPartners, London W1T 7HA, UK.
Leonora G WeilUK Health Security Agency, London SE1 8UG, UK.
Andrew HutchingsDepartment of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Ana ZuriagaUK Health Security Agency, London SE1 8UG, UK.
Dane SatterthwaiteNHS England and NHS Improvement London, London SE1 6LH, UK.
Jennifer L Y YipOffice for Health Improvement and Disparities, London region, London SW1H 0EU, UK.
Cyril EshareturiPublic Health England London, London SE1 8UG, UK.
Julie BillettOffice for Health Improvement and Disparities, London region, London SW1H 0EU, UK.
Ann HepworthNHS England and NHS Improvement London, London SE1 6LH, UK.
Rakesh DodhiaNHS England London Shared Service, London SE1 6LH, UK.
Ellen C SchwartzAssociation of Directors of Public Health, London EC4Y 0HA, UK.
Rachel PennistonUCLPartners, London W1T 7HA, UK.
Emma MordauntUCLPartners, London W1T 7HA, UK.
Sophie BulmerUCLPartners, London W1T 7HA, UK.
Helen BarrattDepartment of Applied Health Research, University College London (UCL), London WC1E 7HB, UK.
John IllingworthUCLPartners, London W1T 7HA, UK.
Joanna InskipOffice for Health Improvement and Disparities, London region, London SW1H 0EU, UK.
Fran BuryNHS England and NHS Improvement London, London SE1 6LH, UK.
Deborah JenkinsRoyal Free London NHS Foundation Trust, London NW3 2QG, UK.
Sandra Mounier-JackDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Rosalind RaineDepartment of Applied Health Research, University College London (UCL), London WC1E 7HB, UK.

Funding

NIH HHS NIHR20092
6 · The paper itself

Abstract

backgroundIn response to the COVID-19 pandemic, the first vaccine was administered in December 2020 in England. However, vaccination uptake has historically been lower in London than in other English regions.

methodsMixed-methods: This comprised an analysis of cumulative percentage uptake across London between 8 December 2020 and 6 June 2021 by vaccine priority cohorts and ethnicity. We also undertook thematic analyses of uptake barriers, interventions to tackle these and key learning from a qualitative survey of 27 London local authority representatives, vaccine plans from London's five Integrated Care Systems and interviews with 38 London system representatives.

resultsVaccine uptake was lower in Black ethnic (57-65% uptake) compared with the White British group (90% uptake). Trust was a critical issue, including mistrust in the vaccine itself and in authorities administering or promoting it. The balance between putative costs and benefits of vaccination created uptake barriers for zero-hour and shift workers. Intensive, targeted and 'hyper-local' initiatives, which sustained community relationships and were not constrained by administrative boundaries, helped tackle these barriers.

conclusionsThe success of the national vaccination programme depended on conceding local autonomy, investing in responsive and long-term partnerships to engender trust through in-depth understanding of communities' beliefs.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesHumansLondonPandemicsCOVID-19 VaccinesVaccinesCOVID-19ethnicityinequalitiesLondonvaccination

Identifiers

PMID35373295
PMCPMC8992332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.